SOFT TISSUE SARCOMAS
Clinical trials for SOFT TISSUE SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMAS trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare sarcomas: immune drug plus chemo tested
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy can help shrink or control advanced soft tissue sarcomas that cannot be removed by surgery. About 45 adults aged 18-75 with certain sarcoma types will receive the combination as their fir…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for rare sarcomas: drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a combination of two drugs, gemcitabine and nab-sirolimus, in people with advanced leiomyosarcoma or other soft-tissue sarcomas that have specific genetic changes (TSC1 or TSC2 mutations). The main goal is to find a safe dose and watch for side effect…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Gene signature may guide sarcoma treatment
Knowledge-focused Recruiting nowThis study is testing whether a genetic signature called CINSARC can help predict how well chemotherapy works in people with soft-tissue sarcomas. About 205 participants with non-spread tumors will receive chemotherapy before surgery, and researchers will track tumor response. Th…
Matched conditions: SOFT TISSUE SARCOMAS
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC